Sirolimus Eluting Coronary Stent System

“Innovative Stent Design with proven blend of anti-proliferative Drug sirolimus & Bioresorbable Polymers,
Contributing to exceptional Acute & Long term Performance”

Drug Release Kinetics

Insignia Neo has proven drug release kinetics. Initial burst release of Sirolimus followed by sustained release up to 40 days. Bioresorbable Polymers completely degrade by hydrolysis & enzymatic degradation which is eventually excreted from the body in the form of COand H2O